Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation (FIOCRUZ), RJ;

Ana Emília Goulart Lemos

Papers (2)

  • OSTEOPONTIN-A ACTIVATES INTERMEDIATE EPITHELIAL MESENCHYMAL PROPERTIES IN c643 THYROID CANCER CELLS

    • 1 Universidade Federal Fluminense/ Departamento de Fisiologia e Farmacologia/ Programa de Pós-Graduação em Ciências Biomédicas - Fisiologia e Farmacologia
    • 2 Instituto de Investigação e Inovação em Saúde (I3S)/ Instituto de Patologia e Imunologia Molecular da Universidade do Porto (IPATIMUP) / Cancer Signalling & Metabolism
    • 3 Oncobiologia / INSTITUTO NACIONAL DE CANCER / Instituto Nacional de Câncer
    • 4 Universidade Federal Fluminense/ Instituto de Humanidades e Saúde/ Departamento de Ciências da Natureza
    Vol 1, 2020 -
    131215
    Cellular Biology
    DR - Doctoral Student

  • PCA3 SILENCING SENSITIZES PROSTATE CANCER CELLS TO DOCETAXEL

    • 1 Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation (FIOCRUZ), RJ;
    • 2 Clinical Research Division, Brazilian National Cancer Institute (INCA), RJ;
    • 3 Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ;
    • 4 Program of Molecular Hemato-Oncology, Brazilian National Cancer Institute (INCA), RJ; Biomedical Institute, Federal Fluminense University (UFF), RJ; Humanities and Health Institute, Federal Fluminense University (UFF), RJ, Brazil.
    Vol 3, 2022 -
    155118
    8. Drugs and/or Natural Products Therapy
    DR - Doctoral Student

Co-authors (9)